MIST
Milestone Pharmaceuticals Inc
NASDAQ: MIST · HEALTHCARE · BIOTECHNOLOGY
$1.80
-1.10% today
Updated 2026-04-30
Market cap
$218.86M
P/E ratio
—
P/S ratio
141.57x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$1 – $3
Volume
2.1M
Milestone Pharmaceuticals Inc (MIST) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $27.59M | $88.08M | $123.43M | $149.97M | $119.85M | $74.48M | $75.23M | $75.50M |
| Cash & equivalents | $10.88M | $85.95M | $119.82M | $72.31M | $114.14M | $7.64M | $13.76M | $25.31M |
| Current assets | $27.55M | $88.05M | $122.50M | $148.69M | $118.92M | $71.80M | $73.03M | $73.93M |
| Total liabilities | $60.71M | $143.29M | $8.51M | $6.86M | $7.25M | $8.13M | $58.45M | $62.35M |
| Current liabilities | $1.60M | $4.53M | $8.33M | $6.16M | $6.78M | $6.14M | $7.23M | $8.13M |
| Long-term debt | $0.00 | $0.00 | — | — | — | — | $49.77M | $53.35M |
| Shareholder equity | $-33.12M | $-55.21M | $114.92M | $143.12M | $112.60M | $66.35M | $16.77M | $13.15M |
| Retained earnings | $-35.09M | $-58.27M | $-113.50M | $-163.47M | $-206.32M | $-266.34M | $-326.03M | $-367.55M |
| Accounts receivable | $543000.00 | $677000.00 | $836000.00 | $948000.00 | $483000.00 | $1.21M | $3.85M | $2.39M |
| Inventory | $0.00 | $0.00 | $-578000.00 | $-725000.00 | $-356000.00 | $-331000.00 | — | — |
| Goodwill | $0.00 | $0.00 | — | — | — | — | — | — |